We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
CCT
451
Country Club Trust
Missouri
$4.59M +$19.4K +126 +0.4%
ACN
452
Advisor Consultant Network
Ohio
$4.59M +$4.45M +28,869 New
AI
453
ArchPoint Investors
Florida
$4.53M
PI
454
PineBridge Investments
New York
$4.53M +$69.3K +450 +2%
IAM
455
Integre Asset Management
New York
$4.44M +$4.3M +27,930 New
Mariner
456
Mariner
Kansas
$4.44M +$417K +2,709 +11%
BC
457
Barnett & Company
Tennessee
$4.39M -$61.6K -400 -1%
KFC
458
Klingenstein Fields & Co
New York
$4.37M -$2.01M -13,054 -32%
JGUA
459
John G. Ullman & Associates
New York
$4.36M -$166K -1,075 -4%
ED
460
Exane Derivatives
France
$4.36M +$2.91M +18,899 +222%
GI
461
GAMCO Investors
Connecticut
$4.35M -$801K -5,200 -16%
RJFSA
462
Raymond James Financial Services Advisors
Florida
$4.31M -$200K -1,295 -5%
BF
463
BOK Financial
Oklahoma
$4.28M -$593K -3,847 -13%
ECM
464
ETrade Capital Management
Virginia
$4.22M -$143K -930 -3%
TCM
465
Tradition Capital Management
New Jersey
$4.22M -$340K -2,207 -8%
HKIM
466
Hayek Kallen Investment Management
Alabama
$4.22M -$1.07M -6,964 -21%
RT
467
Rockland Trust
Massachusetts
$4.19M +$59K +383 +1%
TC
468
Telemus Capital
Michigan
$4.17M +$250K +1,625 +7%
BIM
469
BRC Investment Management
Colorado
$4.16M -$2.89M -18,765 -42%
AB
470
Amalgamated Bank
New York
$4.16M +$11.1K +72 +0.3%
BPIM
471
Brant Point Investment Management
New York
$4.15M +$46.2K +300 +1%
MPA
472
Marvin & Palmer Associates
Delaware
$4.15M +$2.16M +14,000 +116%
Millennium Management
473
Millennium Management
New York
$4.15M -$10M -64,919 -71%
CIM
474
Calvert Investment Management
Maryland
$4.12M +$432K +2,801 +12%
ABC
475
Associated Banc-Corp
Wisconsin
$4.09M -$45K -292 -1%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.